Skip to content

Efficacy and Safety of Nipple Care Butter in Prevention and Treatment in the Cracks, Soreness and Dryness of Nipples in Pregnant Women and Post-Partum Women

An Open Label, Two Group, Multicenter Clinical Study to Evaluate the Efficacy and Safety of Nipple Care Butter in Prevention and Treatment in the Cracks, Soreness and Dryness of Nipples in Pregnant Women and Post-Partum Women

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/04/051658
Enrollment
150
Registered
2023-04-17
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: P929- Feeding problem of newborn, unspecified

Interventions

None listed

Sponsors

Himalaya Wellness Company
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Age: >= 18 years at recruitment. 2) Women with the following: • Group-I: Healthy pregnant females (32 ± 2 weeks of pregnancy) • Group-II: Lactating females: post-delivery having baby less than 3 months old. 3) Subjects with mild to moderate nipple cracks, dryness, soreness/ pain based on Visual Analog Score. 4) For post pregnancy mothers delivered baby within 37-42 weeks. 5) Subjects not having nipple abnormalities (e.g., flattening, indenting, bulging, or any apparent nipple deformity). 6) Subject is willing to give written informed consent and is willing to follow the study procedure. 7) The subject is willing to use test product throughout the study period.

Exclusion criteria

Exclusion criteria: 1) Subjects with high-risk pregnancy. 2) Subjects with severe breast inflammation/Mastitis requiring systemic treatment. 3) History of breast abscess, fungal infections. 4) Known case of dermatological disorders. 5) Subjects delivered abnormal baby. 6) Mothers with babies unable to take feed directly. 7) Subjects with severe nipple cracks, cuts, bleeding, severe pain. 8) Bad obstetric history. 9) Breast Hypoplasia. 10) Having other breast pathology (Breast infection, carcinoma, mastitis, bloody discharge etc.). 11) Women with skin allergies or taking medications for skin allergies. 12) Subjects not willing to discontinue other nipple crack preventing method during application. 13) Subjects who are taking any pain management medication e.g., NSAIDâ??s, pain killers, etc. 14) Subject in a similar clinical study within the previous 4 weeks. 15) Women who are unable to give informed consent.

Design outcomes

Primary

MeasureTime frame
1) To assess the mildness, gentleness, moisturization and soothing of the test product on skin by the Investigator. 2) To evaluate the symptoms assessment using 10-point scoring scale by Investigator. 3) To determine the experience of test product perception and subjective feedback of test product usage on nipples (softens and moisturizes the skin, non-sticky, safe in pregnancy, nipple conditioning before initiating breastfeeding) using questionnaires.Timepoint: Day 1, Day 7, Day 42

Secondary

MeasureTime frame
1) To evaluate the safety of test product in babies by paediatric assessment scale. 2) To determine the experience of test product perception and subjective feedback questionnaire of test product usage on nipples (starts showing relief from 1st use, heals rashes, soothes cracked and sore nipples, reduction in pain, itchiness, dryness, softness and moisturizes the skin, non-sticky, safe for lactating females, breast feeding mother felt eases pain and discomfort, safer for babies too, helps improving breast feeding experience) using questionnaires. 3) To evaluate the product safety by occurrence AEs and SAEs.Timepoint: Day 1, Day 7, Day 42

Countries

India

Contacts

Public ContactMr Hasan Ali Ahmed

Himalaya Wellness Company

dr.swathi.b@himalayawellness.com8660837584

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026